Physician

Michael J. Maresca, M.D.

According to 2025 Medicare claims, Michael Maresca, M.D. (NPI: 1194893727) practices hematology/oncology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 12601-5401. Maresca is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476) and ilumed, LLC (ACO ID: D0005), participating under both the MSSP and REACH models.

Maresca's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 946 traditional Medicare patients, billed 157,138 HCPCS/CPT codes, and received $3,025,903 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,111 prescription claims across 252 beneficiaries totaling $3,699,935 in drug costs, led by Revlimid (Lenalidomide). DME data shows 172 claims. Open Payments data shows 3 records totaling $67. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,040,389 to $3,025,903. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,112,690 and ending at $3,699,935. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,965 and ending at $913.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,197	207,106	$2,040,389
2016	1,158	259,233	$2,371,111
2017	1,127	181,830	$2,026,282
2018	1,168	253,063	$2,653,889
2019	1,223	212,714	$2,975,129
2020	1,126	288,727	$3,468,509
2021	1,230	217,303	$3,423,121
2022	1,147	280,587	$4,236,036
2023	1,074	188,185	$2,960,485
2024	946	157,138	$3,025,903

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	254	1,159	$2,112,690
2016	264	1,149	$1,856,105
2017	249	1,000	$1,726,311
2018	291	1,309	$3,137,376
2019	289	1,373	$3,998,559
2020	227	767	$1,250,932
2021	186	621	$1,292,660
2022	204	575	$1,092,260
2023	214	737	$1,746,464
2024	252	1,111	$3,699,935

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$1,659
2016	N/R	59	$4,574
2017	N/R	42	$1,570
2018	N/R	46	$1,666
2019	N/R	31	$1,138
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	86	$59,056
2023	N/R	200	$139,328
2024	N/R	172	$104,034

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	469	1,146	$10
36415	Insertion of needle into vein for collection of blood sample	440	965	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	564	1,795	$8
83615	Lactate dehydrogenase (enzyme) level	448	1,138	$6
84100	Phosphate level	430	1,122	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	28	784	$508,709
Darzalex Faspro	Daratumumab-Hyaluronidase-Fihj	27	756	$382,034
Jakafi	Ruxolitinib Phosphate	22	660	$375,432
Venclexta	Venetoclax	15	450	$232,969
Eliquis	Apixaban	130	7,635	$144,962

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4199	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix	N	N/R	34	$78,796
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	38	$15,380
B4224	Parenteral nutrition administration kit, per day	N	N/R	38	$6,776
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	38	$2,169
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$735

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$67	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael J. Maresca, M.D.?

Tedicare shows public-source Medicare data for Michael J. Maresca, M.D. (NPI 1194893727), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael J. Maresca, M.D. have ACO affiliation data?

Michael J. Maresca, M.D. is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476) and ilumed, LLC (REACH, ACO ID D0005).

What billing organization is linked to Michael J. Maresca, M.D.?

Michael J. Maresca, M.D. is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Michael J. Maresca, M.D. have Open Payments data?

Michael J. Maresca, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.